According to Statifacts, the global clinical trials market size is calculated at USD 126.30 billion in 2025 and is expected ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 35 tables and 45 figures, this 111-page report ?Europe Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 99 tables and 79 figures, this 186-page report ?Europe Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices ...

Novartis, Eli Lilly and more put on their deal-making caps, Bristol Myers Squibb targets $2 billion in savings through 2027, ...

Dealmaking in the Asia Pacific (APAC) region took off this week, with the latest showcasing Genome & Co.’s licensing deal with Ellipses Pharma Ltd. for GENA-104, a phase I-ready immuno-oncology asset, ...

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...

Europe Is Behind In AI, and France’s investment in AI isn’t enough to change that. What should Europe do to compete in AI?

Novo Nordisk boasts 45 million customers using its drug, which has caused a revolution in weight-loss treatment. But competitors are nipping at its heels.

Olix Pharmaceuticals Inc. walked the talk in realizing a new $630 million licensing deal with Eli Lilly and Co. for its ...